0.785
price down icon3.09%   -0.025
 
loading
前日終値:
$0.81
開ける:
$0.8005
24時間の取引高:
417.98K
Relative Volume:
0.25
時価総額:
$94.17M
収益:
-
当期純損益:
$-225.14M
株価収益率:
-0.4005
EPS:
-1.96
ネットキャッシュフロー:
$-192.27M
1週間 パフォーマンス:
+5.02%
1か月 パフォーマンス:
+11.46%
6か月 パフォーマンス:
+65.96%
1年 パフォーマンス:
-39.15%
1日の値動き範囲:
Value
$0.78
$0.8199
1週間の範囲:
Value
$0.75
$0.855
52週間の値動き範囲:
Value
$0.3546
$2.74

Invivyd Inc Stock (IVVD) Company Profile

Name
名前
Invivyd Inc
Name
セクター
Healthcare (1164)
Name
電話
(781) 819-0080
Name
住所
1601 TRAPELO ROAD, WALTHAM
Name
職員
100
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
IVVD's Discussions on Twitter

IVVD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IVVD
Invivyd Inc
0.785 97.17M 0 -225.14M -192.27M -1.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Invivyd Inc Stock (IVVD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-04-05 アップグレード Guggenheim Neutral → Buy
2024-03-26 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-12-19 アップグレード Morgan Stanley Underweight → Equal-Weight
2023-05-01 開始されました H.C. Wainwright Buy

Invivyd Inc (IVVD) 最新ニュース

pulisher
Jul 25, 2025

Is Invivyd Inc. a good long term investmentFree Stock Market Knowledge Sharing - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Invivyd Inc. stock priceHigh-octane financial growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Invivyd Inc. stockOutstanding yields - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Invivyd Inc. Stock Analysis and ForecastFree Investment Portfolio Suggestions - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Scientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for Long COVID and COVID-19 Post-Vaccination Syndrome - The Manila Times

Jul 23, 2025
pulisher
Jul 23, 2025

Yale immunobiologist Iwasaki joins Invivyd’s Long COVID research group - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Yale immunobiologist Iwasaki joins Invivyd’s Long COVID research group By Investing.com - Investing.com South Africa

Jul 23, 2025
pulisher
Jul 23, 2025

Invivyd, Inc.'s (NASDAQ:IVVD) Shift From Loss To Profit - simplywall.st

Jul 23, 2025
pulisher
Jul 22, 2025

How Invivyd Inc. stock performs during market volatilityFree Stock Market Swing Trading Strategies - Newser

Jul 22, 2025
pulisher
Jul 17, 2025

Goldman Sachs Shines in Q2 2025 Earnings Call - The Globe and Mail

Jul 17, 2025
pulisher
Jul 15, 2025

Why Invivyd Inc. stock attracts strong analyst attentionFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Invivyd Inc. stock price move sharplyFree VIP Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Why Shares of Nebius Group Are Rocketing Higher Today - The Globe and Mail

Jul 14, 2025
pulisher
Jul 02, 2025

Invivyd Launches SPEAR Study for Long COVID Therapy - TipRanks

Jul 02, 2025
pulisher
Jul 02, 2025

Invivyd forms research group to study monoclonal antibodies for Long COVID - Investing.com

Jul 02, 2025
pulisher
Jul 02, 2025

Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome - TradingView

Jul 02, 2025
pulisher
Jun 27, 2025

Invivyd (IVVD) Receives Continued 'Buy' Rating from D. Boral Cap - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

H.C. Wainwright maintains buy rating on Invivyd stock after positive data - Investing.com

Jun 27, 2025
pulisher
Jun 26, 2025

Invivyd’s COVID-19 antibody shows promising safety profile in trial - Investing.com

Jun 26, 2025
pulisher
Jun 26, 2025

Invivyd’s COVID-19 antibody shows promising safety profile in trial By Investing.com - Investing.com UK

Jun 26, 2025
pulisher
Jun 16, 2025

Trading Day Triumph: Invivyd Inc (IVVD) Ends at 0.79, a -6.47 Surge/Plunge - DWinneX

Jun 16, 2025
pulisher
Jun 02, 2025

COVID’s remaining biotech contenders navigate a dwindling market - Pharma Voice

Jun 02, 2025
pulisher
May 29, 2025

H.C. Wainwright Lowers Invivyd (IVVD) PT to $5 Amid Q1 2025 Revenue Shortfall - Insider Monkey

May 29, 2025
pulisher
May 29, 2025

Invivyd stock target cut to $5 by H.C. Wainwright, retains Buy rating - Investing.com Nigeria

May 29, 2025
pulisher
May 29, 2025

Invivyd (NASDAQ:IVVD) Price Target Lowered to $5.00 at HC Wainwright - Defense World

May 29, 2025
pulisher
May 28, 2025

Invivyd (IVVD) Analyst Rating Update: Price Target Lowered | IVV - GuruFocus

May 28, 2025

Invivyd Inc (IVVD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Invivyd Inc (IVVD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
MCGUIRE TERRANCE
Director
Dec 27 '24
Sale
0.52
83,744
43,647
3,256,776
MCGUIRE TERRANCE
Director
Dec 30 '24
Sale
0.48
86,545
41,784
3,170,231
MCGUIRE TERRANCE
Director
Dec 20 '24
Sale
0.42
119,805
50,725
3,568,274
MCGUIRE TERRANCE
Director
Dec 26 '24
Sale
0.54
83,817
45,563
3,340,520
MCGUIRE TERRANCE
Director
Dec 24 '24
Sale
0.51
68,161
34,503
3,424,337
MCGUIRE TERRANCE
Director
Dec 23 '24
Sale
0.45
75,776
34,076
3,492,498
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):